Advanced mesenchymal stromal cell-based therapies for neurodegenerative diseases are
widely investigated in preclinical models. Mesenchymal stromal cells are well positioned as …

Advanced mesenchymal stromal cell-based therapies for neurodegenerative diseases are
widely investigated in preclinical models. Mesenchymal stromal cells are well positioned as …

Many preclinical studies using adult Mesenchymal Stromal Cells (MSCs) for
neurodegenerative diseases show promising results. However, there is a lack of …

Background Advanced therapies using adult mesenchymal stromal cells (MSCs) for
neurodegenerative diseases are not effectively translated into the clinic. The cross talk …

Mesenchymal stromal cell (MSC) therapy to treat neurodegenerative diseases has not been
as successful as expected in some preclinical studies. Because preclinical research is so …

Background Glaucoma is a blinding degenerative neuropathy in which the death of retinal
ganglion cells (RGCs) causes progressive loss of visual field and eventually vision …

Adult marrow derived mesenchymal stromal cells are currently in clinical trials for various
neurodegenerative diseases. Through secretion of soluble and insoluble trophic factors …

Purpose Cellular therapy with mesenchymal stem cells (MSC) is emerging as an effective
option to treat optic neuropathies. In models of retinal degeneration, MSC injected in the …

An inflammatory response is often observed in neurological diseases, being characterized
sometimes by activation of adaptive cells (T and B lymphocytes) and, almost inexorably, of …

Although cell transplantation is increasingly suggested to be beneficial for the treatment of
various neurodegenerative diseases, the therapeutic application of such intervention is …